Pharmacotherapy of senile dementia.
D000328:Adult; D000367:Age Factors; D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy; D000661:Amphetamine / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D003704:Dementia / Q000150:complications / Q000188:drug therapy*; D003863:Depression / Q000150:complications; D004088:Dihydroergotoxine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008568:Memory; D008774:Methylphenidate / Q000627:therapeutic use; D010208:Papaverine / Q000627:therapeutic use; D011343:Procaine / Q000627:therapeutic use; D011760:Pyrrolidinones / Q000627:therapeutic use; D013881:Thioridazine / Q000627:therapeutic use
D000929:Antidepressive Agents, Tricyclic; D011760:Pyrrolidinones; D004088:Dihydroergotoxine; D008774:Methylphenidate; D011343:Procaine; D000661:Amphetamine; D010208:Papaverine; D013881:Thioridazine